Berkshire Hathaway accelerated its share repurchase program in the second quarter, buying back $4.5 billion of its own stock at the fastest pace in several years. The unusual detail in Berkshire’s buyback framework is that repurchases require approval from both CEO Greg Abel and Chairman Warren Buffett that the shares trade below intrinsic value—setting the stage for an argument that investors may be underpricing the conglomerate’s operating earnings.
Key takeaways
- Price move: Berkshire announced a $4.5 billion buyback in the second quarter.
- Catalyst: The company repurchased shares under its internal rule that leaders agree the stock is undervalued.
- Valuation implication: The operating business is described as valued at just over 10 times trailing earnings, a notably low multiple versus broad-market benchmarks.
- What to watch: Investors will focus on whether continued repurchases persist alongside earnings strength and the durability of insurance cash generation.
What drove the buyback pace higher
Berkshire Hathaway said it bought back $4.5 billion of its own shares in the second quarter, marking its most aggressive pace of repurchases in several years. Unlike many companies that repurchase stock based primarily on capital-allocation priorities set by management, Berkshire’s approach includes a valuation gate: CEO Greg Abel and Chairman Warren Buffett must both agree the stock is trading below intrinsic value before repurchases proceed.
That decision matters for investors because it frames buybacks not simply as a use of excess capital, but as a signal that Berkshire’s leadership believes the market is pricing the conglomerate below its underlying earning power.
Berkshire’s valuation breakdown: cash, investments, and operating earnings
The analysis in the source centers on a “sum-of-the-parts” view, separating Berkshire into liquid resources and the value assigned to its operating businesses. As stated in the article, Berkshire’s market capitalization is about $1.09 trillion.
Two components are presented as relatively straightforward to estimate: cash and Treasuries of $365.5 billion on the balance sheet at the end of the second quarter, and a stock portfolio valued at about $360.5 billion. Subtracting these figures from the overall market value implies that Berkshire’s operating businesses are valued at roughly $364 billion.
On earnings, the article cites operating results over the past four quarters of just over $48 billion, and after subtracting investment income from the insurance business, it estimates operating income of $35.8 billion. Using those figures, the operating businesses are described as trading at about 10.2 times trailing earnings.
Market reaction and what investors may read into the multiple
While the article does not attribute a specific day’s share price movement, the underlying implication for the market is the same: leadership appears comfortable shrinking the share count at a perceived discount to intrinsic value.
The piece contrasts the estimated operating multiple with broader benchmarks. It notes that the average stock in the S&P 500 trades at about 28 times earnings, while it also cites examples of components within Berkshire—such as energy companies and the railroad business BNSF—trading at higher multiples (mid-teens for energy and about 22 times for railroads, per the article’s comparisons). Against that backdrop, a roughly 10x valuation for Berkshire’s operating earnings is framed as unusually low.
At the same time, the article flags reasons the discount may not fully reflect a “cheap” bargain. It points out that insurance companies often trade at low double-digit earnings multiples and that Berkshire’s GEICO has underperformed peers in recent years. In other words, investors assessing whether the buybacks represent value creation will likely consider whether operating earnings growth and competitive positioning can offset any structural discount applied by the market to insurance profitability.
Bigger picture: why the buyback framework matters now
Berkshire’s buyback authorization structure differentiates it from peers. Requiring both Abel and Buffett to agree the stock is below intrinsic value effectively increases the threshold for repurchases, which can make sustained buyback activity more informative to investors than standard capital-return programs.
For shareholders, the key question is not only whether Berkshire’s operating businesses trade cheaply on trailing earnings, but whether that valuation persists as results unfold—especially in insurance and in the earnings contribution from non-insurance operations. If earnings trends support the current level of profitability, buybacks at a low multiple can be accretive; if earnings weaken, the case for repurchases at any valuation becomes less clear.
Looking ahead, investors will likely watch Berkshire’s quarterly earnings and guidance on operating income, insurance performance, and capital allocation. With the company continuing to operate under its intrinsic-value approval process, future buyback pace and the underlying earnings trajectory may be the most important signals for whether the market’s discount to Berkshire’s operating earnings narrows—or widens.
